Targeting the global regulator Lsr2 as a novel approach for anti-tuberculosis drug development

Expert Review of Anti-Infective Therapy

Volumn 10, Issue 9, 2012, Pages 1049-1053

  Liu, Jun ^a   Gordon, Blair RG ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

global regulator; H NS; Lsr2; Mycobacterium tuberculosis; nucleoid associated protein

Indexed keywords

CAPSAICIN; DNA; HISTONE; LEPROSY SERUM REACTIVE CLONE 2; NUCLEAR PROTEIN; UNCLASSIFIED DRUG;

BACTERIAL GENOME; BACTERIAL METABOLISM; BACTERIAL VIRULENCE; DNA SEQUENCE; DRUG RESEARCH; DRUG TARGETING; GENE EXPRESSION REGULATION; GENE SILENCING; HORIZONTAL GENE TRANSFER; HUMAN; IMMUNOSURVEILLANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SEQUENCE HOMOLOGY; TRANSCRIPTION REGULATION; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DNA-BINDING PROTEINS; DRUG DESIGN; GENE EXPRESSION REGULATION, BACTERIAL; MYCOBACTERIUM TUBERCULOSIS; VIRULENCE;

EID: 84868102729     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.12.86     Document Type: Review

References (48)

1. Zhang Y., The magic bullets and tuberculosis drug targets, Annual Review of Pharmacology and Toxicology, 2005 45 529-564 DOI 10.1146/annurev.pharmtox.45. 120403.100120.
2. Sahbazian B, Weis SE. Treatment of active tuberculosis: challenges and prospects. Clin. Chest Med. 26(2), 273-282, vi (2005).
3. Neff M. ATS, CDC, and IDSA update recommendations on the treatment of tuberculosis. Am. Fam. Physician 68(9), 1854-1862 (2003).
4. WHO. WHO Report: Global Tuberculosis Control. WHO, Geneva, Switzerland (2011).
5. Zhang Y. The magic bullets and tuberculosis drug targets. Annu. Rev. Pharmacol. Toxicol. 45, 529-564 (2005).
6. Corbett EL, Watt CJ, Walker N et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med. 163(9), 1009-1021 (2003).
7. Clatworthy AE, Pierson E, Hung DT. Targeting virulence: a new paradigm for antimicrobial therapy. Nat. Chem. Biol. 3(9), 541-548 (2007).
8. Laal S, Sharma YD, Prasad HK et al. Recombinant fusion protein identified by lepromatous sera mimics native Mycobacterium leprae in T-cell responses across the leprosy spectrum. Proc. Natl Acad. Sci. USA 88(3), 1054-1058 (1991).
9. Chen JM, German GJ, Alexander DC, Ren H, Tan T, Liu J. Roles of Lsr2 in colony morphology and biofilm formation of Mycobacterium smegmatis. J. Bacteriol. 188(2), 633-641 (2006).
10. Kocíncová D, Singh AK, Beretti JL et al. Spontaneous transposition of IS1096 or ISMsm3 leads to glycopeptidolipid overproduction and affects surface properties in Mycobacterium smegmatis. Tuberculosis (Edinb.) 88(5), 390-398 (2008).
11. Arora K, Whiteford DC, Lau-Bonilla D, Davitt CM, Dahl JL. Inactivation of lsr2 results in a hypermotile phenotype in Mycobacterium smegmatis. J. Bacteriol. 190(12), 4291-4300 (2008).
12. Chen JM, Ren H, Shaw JE et al. Lsr2 of Mycobacterium tuberculosis is a DNA-bridging protein. Nucleic Acids Res. 36(7), 2123-2135 (2008).
13. Dorman CJ. H-NS, the genome sentinel. Nat. Rev. Microbiol. 5(2), 157-161 (2007).
14. Gordon BR, Imperial R, Wang L, Navarre WW, Liu J. Lsr2 of Mycobacterium represents a novel class of H-NS-like proteins. J. Bacteriol. 190(21), 7052-7059 (2008).
15. Werlang IC, Schneider CZ, Mendonça JD, Palma MS, Basso LA, Santos DS. Identification of Rv3852 as a nucleoid-associated protein in Mycobacterium tuberculosis. Microbiology 155(Pt 8), 2652-2663 (2009).
16. Sharadamma N, Harshavardhana Y, Singh P, Muniyappa K. Mycobacterium tuberculosis nucleoid-associated DNA-binding protein H-NS binds with high-affinity to the Holliday junction and inhibits strand exchange promoted by RecA protein. Nucleic Acids Res. 38(11), 3555-3569 (2010).
17. Arold ST, Leonard PG, Parkinson GN, Ladbury JE. H-NS forms a superhelical protein scaffold for DNA condensation. Proc. Natl Acad. Sci. USA 107(36), 15728-15732 (2010).
18. Gordon BR, Li Y, Wang L et al. Lsr2 is a nucleoid-associated protein that targets AT-rich sequences and virulence genes in Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 107(11), 5154-5159 (2010).
19. Gordon BR, Li Y, Cote A et al. Structural basis for recognition of AT-rich DNA by unrelated xenogeneic silencing proteins. Proc. Natl Acad. Sci. USA 108(26), 10690-10695 (2011).
20. Colangeli R, Helb D, Vilchèze C et al. Transcriptional regulation of multi-drug tolerance and antibiotic-induced responses by the histone-like protein Lsr2 in M. tuberculosis. PLoS Pathog. 3(6), e87 (2007).
21. Daubin V, Moran NA, Ochman H. Phylogenetics and the cohesion of bacterial genomes. Science 301(5634), 829-832 (2003).
22. Jang J, Becq J, Gicquel B, Deschavanne P, Neyrolles O. Horizontally acquired genomic islands in the tubercle bacilli. Trends Microbiol. 16(7), 303-308 (2008).
23. Lucchini S, Rowley G, Goldberg MD, Hurd D, Harrison M, Hinton JC. H-NS mediates the silencing of laterally acquired genes in bacteria. PLoS Pathog. 2(8), e81 (2006).
24. Navarre WW, Porwollik S, Wang Y et al. Selective silencing of foreign DNA with low GC content by the H-NS protein in Salmonella. Science 313(5784), 236-238 (2006).
25. Groisman EA, Ochman H. How Salmonella became a pathogen. Trends Microbiol. 5(9), 343-349 (1997).
26. Ochman H, Lawrence JG, Groisman EA. Lateral gene transfer and the nature of bacterial innovation. Nature 405(6784), 299-304 (2000).
27. Dorman CJ. Regulatory integration of horizontally-transferred genes in bacteria. Front. Biosci. 14, 4103-4112 (2009).
28. Sorek R, Zhu Y, Creevey CJ, Francino MP, Bork P, Rubin EM. Genome-wide experimental determination of barriers to horizontal gene transfer. Science 318(5855), 1449-1452 (2007).
29. Becq J, Gutierrez MC, Rosas-Magallanes V et al. Contribution of horizontally acquired genomic islands to the evolution of the tubercle bacilli. Mol. Biol. Evol. 24(8), 1861-1871 (2007).
30. Abdallah AM, Gey van Pittius NC, Champion PA et al. Type VII secretion -mycobacteria show the way. Nat. Rev. Microbiol. 5(11), 883-891 (2007).
31. Fortune SM, Jaeger A, Sarracino DA et al. Mutually dependent secretion of proteins required for mycobacterial virulence. Proc. Natl Acad. Sci. USA 102(30), 10676 - 10681 (2005).
32. Camacho LR, Ensergueix D, Perez E, Gicquel B, Guilhot C. Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis. Mol. Microbiol. 34(2), 257-267 (1999).
33. Cox JS, Chen B, McNeil M, Jacobs WR Jr. Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Nature 402(6757), 79-83 (1999).
34. Reed MB, Domenech P, Manca C et al. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431(7004), 84-87 (2004).
35. Yu J, Tran V, Li M et al. Both phthiocerol dimycocerosates and phenolic glycolipids are required for virulence of Mycobacterium marinum. Infect. Immun. 80(4), 1381-1389 (2012).
36. Cole ST, Brosch R, Parkhill J et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393(6685), 537-544 (1998).
37. Sampson SL. Mycobacterial PE/PPE proteins at the host-pathogen interface. Clin. Dev. Immunol. 2011, 497203 (2011).
38. Dong D, Wang D, Li M et al. PPE38 modulates the innate immune response and is required for Mycobacterium marinum virulence. Infect. Immun. 80(1), 43-54 (2012).
39. Fleischmann RD, Alland D, Eisen JA et al. Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J. Bacteriol. 184(19), 5479-5490 (2002).
40. Choudhary RK, Mukhopadhyay S, Chakhaiyar P et al. PPE antigen Rv2430c of Mycobacterium tuberculosis induces a strong B-cell response. Infect. Immun. 71(11), 6338-6343 (2003).
41. Park KT, Dahl JL, Bannantine JP et al. Demonstration of allelic exchange in the slow-growing bacterium Mycobacterium avium subsp. paratuberculosis, and generation of mutants with deletions at the pknG, relA, and lsr2 loci. Appl. Environ. Microbiol. 74(6), 1687-1695 (2008).
42. Colangeli R, Haq A, Arcus VL et al. The multifunctional histone-like protein Lsr2 protects mycobacteria against reactive oxygen intermediates. Proc. Natl Acad. Sci. USA 106(11), 4414-4418 (2009).
43. Oshima T, Ishikawa S, Kurokawa K, Aiba H, Ogasawara N. Escherichia coli histone-like protein H-NS preferentially binds to horizontally acquired DNA in association with RNA polymerase. DNA Res. 13(4), 141-153 (2006).
44. Dame RT. The role of nucleoid-associated proteins in the organization and compaction of bacterial chromatin. Mol. Microbiol. 56(4), 858-870 (2005).
45. Dorman CJ. H-NS: a universal regulator for a dynamic genome. Nat. Rev. Microbiol. 2(5), 391-400 (2004).
46. Spurio R, Dürrenberger M, Falconi M, La Teana A, Pon CL, Gualerzi CO. Lethal overproduction of the Escherichia coli nucleoid protein H-NS: ultramicroscopic and molecular autopsy. Mol. Gen. Genet. 231(2), 201-211 (1992).
47. Yamasaki S, Asakura M, Neogi SB, Hinenoya A, Iwaoka E, Aoki S. Inhibition of virulence potential of Vibrio cholerae by natural compounds. Indian J. Med. Res. 133, 232-239 (2011).
48. Boshoff HI, Barry CE 3rd. Tuberculosis - metabolism and respiration in the absence of growth. Nat. Rev. Microbiol. 3(1), 70-80 (2005). (Pubitemid 40261816)